Terence Flotte, MD
Dean of the School of Medicine, UMass Medical School
Pediatrician and Gene Therapy Investigator
1 / 14
Clinical Trials: In the early phase, it’s about both gaining knowledge and trying to help. To figure it out, we need some families to step up and go first
Clinical Trials: Inclusion and Exclusion Criteria; Age and Ability of the child are often key factors
Clinical Trials: Phase 1 defined – focusing on safety, with less certainty about benefit. Phase 1 trials for rare disease are designed for some efficacy
Clinical Trials: Inclusion and Exclusion criteria defined.
Clinical Trials: The Role of the Principal Investigator, Sponsor, IRB and FDA.
Clinical Trials: Informed Consent defined. Parents and providers together making the best decision based on the limited information available
Clinical Trials: Limited slots - first come, first served and screened re criteria.
Clinical Trials are designed to get to FDA approval ASAP
Clinical Trials: Efficacy and End Points defined. End points are indicators on the road to efficacy.
Clinical Trials: With Gene Therapy, it is ONE and DONE
Clinical Trials: Dose escalation, Phase by Phase
Compassionate use is no substitute for the trial pathway
Clinical Trials: Defining Compassionate Use, Expanded Access
Clinical Trials: Timing is everything. Participate early or wait for Phase 3?
Made possible by a grant from: